PL362702A1 - Kompozycja farmaceutyczna - Google Patents

Kompozycja farmaceutyczna

Info

Publication number
PL362702A1
PL362702A1 PL02362702A PL36270202A PL362702A1 PL 362702 A1 PL362702 A1 PL 362702A1 PL 02362702 A PL02362702 A PL 02362702A PL 36270202 A PL36270202 A PL 36270202A PL 362702 A1 PL362702 A1 PL 362702A1
Authority
PL
Poland
Prior art keywords
phenoxyalkal
diabetes
compound
treatment
pharmaceutical composition
Prior art date
Application number
PL02362702A
Other languages
English (en)
Inventor
Gerard Moinet
Gerard Botton
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL362702A1 publication Critical patent/PL362702A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02362702A 2001-03-19 2002-03-08 Kompozycja farmaceutyczna PL362702A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103704A FR2822069B1 (fr) 2001-03-19 2001-03-19 Composition pharmaceutique comprenant un compose stimulant la secretion d'insuline et un derive de thiazolidinedione et son utilisation pour la preparation de medicamments destines a traiter le diabete

Publications (1)

Publication Number Publication Date
PL362702A1 true PL362702A1 (pl) 2004-11-02

Family

ID=8861295

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02362702A PL362702A1 (pl) 2001-03-19 2002-03-08 Kompozycja farmaceutyczna

Country Status (9)

Country Link
US (1) US20040097567A1 (pl)
EP (1) EP1370269A2 (pl)
KR (1) KR20040025898A (pl)
AR (1) AR033434A1 (pl)
BR (1) BR0208122A (pl)
CA (1) CA2442000A1 (pl)
FR (1) FR2822069B1 (pl)
PL (1) PL362702A1 (pl)
WO (1) WO2002074228A2 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749583B1 (fr) * 1996-06-07 1998-08-21 Lipha Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
EA200601145A1 (ru) * 1998-11-12 2009-04-28 Смитклайн Бичам П.Л.С. Таблетка замедленного высвобождения сенсибилизатора к инсулину и других антидиабетических агентов

Also Published As

Publication number Publication date
FR2822069A1 (fr) 2002-09-20
WO2002074228A3 (en) 2003-02-20
FR2822069B1 (fr) 2003-06-20
BR0208122A (pt) 2004-03-02
KR20040025898A (ko) 2004-03-26
WO2002074228A2 (en) 2002-09-26
AR033434A1 (es) 2003-12-17
US20040097567A1 (en) 2004-05-20
CA2442000A1 (en) 2002-09-26
EP1370269A2 (en) 2003-12-17

Similar Documents

Publication Publication Date Title
EG24124A (en) Pharmaceutical compositions for the treatment of type-II diabetes mellitus
PL370818A1 (pl) Forma dawkowania przeznaczona do leczenia cukrzycy
IL158593A (en) Arylsulfonamide compounds, process for preparation thereof and pharmaceutical compositions for the treatment of obesity, type ii diabetes and cns-disorders
ZA200300434B (en) Medicinal herbal compounds for the prevention and treatment of diabetes.
IL213809A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
HRP20030949A2 (en) Pulmonary administration of chemically modified insulin
HUP0303876A3 (en) Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2002315814A1 (en) Medicinal composition for treatment of interstitial cystitis
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
MXPA03005980A (es) Composiciones para administracion nasal de insulina.
IL162853A0 (en) The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
EP1532979A4 (en) DRUG COMPOSITION FOR REGULATING GLYCEMIA
PL362702A1 (pl) Kompozycja farmaceutyczna
GB0212790D0 (en) Medicament for the treatment of diabetes
HUP0301137A3 (en) Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same
AU2003273192A8 (en) Compounds and compositions for the treatment of diabetes and diabetes-related disorders
AU2002326191A1 (en) Pharmaceutical composition comprising an extract of elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications
HUP0300313A3 (en) Compound, pharmaceutical composition containing it and its use for the treatment of pain
AU2003235434A1 (en) Use of a photosensitising compound for the preparation of a pharmaceutical composition for treating of burns, and a method of treating burns
AU2002350563A1 (en) Pharmaceutical composition comprising a glitazone and a thiazolidinedione derivative, and use thereof for treating diabetes
AU2003226768A1 (en) Combination of insulin and a thiazolidinedione derivative, and use thereof for treating diabetes
AU2002338753A1 (en) Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes
HK1064311A (en) Medicinal herbal compounds for the prevention and treatment of diabetes
HU0300989D0 (en) Pharmaceutical composition for the prophylaxis and treatment of diabetes